MiMedx Group
MDXG • NASDAQ
MiMedx Group is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph H. Capper, with a market cap of $475.4M.
Market Cap$475.4M
Employees895.0
CEOJoseph H. Capper
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 29, 2026 · In 5 daysAfter Market Close · Q1 2026
Financials
MiMedx Group FAQ
Common questions about MiMedx Group
MiMedx Group is scheduled to report earnings for Q1 2026 on April 29, 2026 after market close. Analysts estimate revenue of $65.8M.
MiMedx Group has approximately 895 employees.